Triple Quad LC-MS (with Agilent Trade-in; Dietary supplements)

The Food and Drug Administration is seeking to acquire a triple quadrupole liquid chromatography-mass spectrometry system to enhance analytical capabilities for dietary supplement method development. This new instrument will be integrated with an existing liquid chromatography platform to replace aging equipment that has reached the end of its operational life, ensuring continued accuracy and reliability in laboratory testing. The procurement includes a trade-in option for an Agilent system, indicating a strategic effort to leverage existing assets while upgrading to a more advanced detection system. The acquisition falls under NAICS code 541990 for other scientific and technical consulting services, reflecting its use in support of regulatory science and analytical method validation. The point of contact for program inquiries is Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov, with the contracting officer position pending assignment. The opportunity was posted on May 25, 2026, and is currently listed as a forecast, suggesting it is in the early planning phase with formal solicitation expected to follow. The place of performance and specific location details are not yet defined, but the instrument will be deployed within the FDA’s operational laboratory environment to support post-market surveillance and compliance activities related to dietary supplements.